BIO-TECHNE Corp — Director's Dealing 2017

Oct 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-10-26

Reporting Person: WIENS HAROLD J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-26	Common Stock	A	739.00	$0.00	Acquired	4212.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-26	Stock Option (right to buy)	$125.05	A	3125.00	Acquired	2027-10-26	Common Stock (3125.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Option (right to buy)	$87.83	2024-05-15	Common Stock (2000.00)	2000.00	Direct
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260.00)	4260.00	Direct
Stock Options (Right to buy)	$101.19	2026-10-26	Common Stock (3985.00)	3985.00	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/26/18) or the date of Bio-Techne's 2018 annual meeting of shareholders.